Headline
The latest stories from AHA Today.
The Food and Drug Administration warned that Curative’s SARS-Cov-2 test could produce false results and that health care providers should strictly follow its authorization and labeling.
The Food and Drug Administration reminded the public of the importance of receiving COVID-19 vaccines in accordance to their agency authorizations, a process that FDA said will safely provide the “remarkable” levels of protection observed during large, randomized clinical trials.
The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology should extend the deadline to comply with its final rule implementing information blocking provisions of the 21st Century Cures Act to 2022 or six months after the end of the COVID-19…
The National Quality Forum’s Measure Applications Partnership recently initiated its statutorily required annual review of the quality measures that the Centers for Medicare & Medicaid Services is considering for use in federal programs.
The AHA praised a Centers for Medicare & Medicaid Services’ proposed rule that would remove inappropriate barriers to patient care by streamlining the prior authorization processes for the impacted health plans; however the association said it was deeply disappointed that CMS chose not to…
New research conducted by the National Institutes of Health is shedding light on how COVID-19 affects patients’ brains.
The Federal Emergency Management Agency has extended through June 30, 2021, with changes, a temporary final rule designating certain scarce health and medical resources exclusively for domestic use during the COVID-19 pandemic.
The Food and Drug Administration last month added to its device shortage list several device types, along with clarifying notes and resource links.
The House of Representatives is expected to consider a continuing resolution that extends current federal funding levels through Dec. 20 while Congress continues negotiations on an omnibus appropriations bill and a COVID-19 relief package.
The AHA urged congressional leaders not include in any end-of-the year legislative package provisions that would impact private contract negotiations between providers – including hospitals and physicians – and health insurance plans.